Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection

Maadhava Ellaurie, Arye Rubinstein

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Serum concentrations of beta-2-microglobulin (B2-M) were correlated with disease outcome in 40 children infected by the human immunodeficiency virus. Serum B2-M serum concentrations below 3.0 mg/100 ml or decreasing concentrations were indicative of a stable disease course but were also noted preterminally in lymphopenic children. Of 20 patients with B2-M concentrations above 3.0 mg/liter, 12 had a progressive disease course and 8 remained stable. In the latter 8 patients the B2-M values decreased with time. Elevated B2-M concentrations were also noted in infants younger than 1 year of age and denoted active human immunodeficiency virus infection. B2-M serum concentrations are a useful prognostic marker in human immunodeficiency virus-infected children.

Original languageEnglish (US)
Pages (from-to)807-809
Number of pages3
JournalPediatric Infectious Disease Journal
Volume9
Issue number11
StatePublished - 1990

Fingerprint

beta 2-Microglobulin
Virus Diseases
HIV
Pediatrics
Serum

Keywords

  • Acquired immunodeficiency syndrome
  • Beta-2-microglobulin
  • Early markers
  • Human immunodeficiency virus infection

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection. / Ellaurie, Maadhava; Rubinstein, Arye.

In: Pediatric Infectious Disease Journal, Vol. 9, No. 11, 1990, p. 807-809.

Research output: Contribution to journalArticle

@article{4ae1e051fedf4526afc7d8dc561b9bd1,
title = "Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection",
abstract = "Serum concentrations of beta-2-microglobulin (B2-M) were correlated with disease outcome in 40 children infected by the human immunodeficiency virus. Serum B2-M serum concentrations below 3.0 mg/100 ml or decreasing concentrations were indicative of a stable disease course but were also noted preterminally in lymphopenic children. Of 20 patients with B2-M concentrations above 3.0 mg/liter, 12 had a progressive disease course and 8 remained stable. In the latter 8 patients the B2-M values decreased with time. Elevated B2-M concentrations were also noted in infants younger than 1 year of age and denoted active human immunodeficiency virus infection. B2-M serum concentrations are a useful prognostic marker in human immunodeficiency virus-infected children.",
keywords = "Acquired immunodeficiency syndrome, Beta-2-microglobulin, Early markers, Human immunodeficiency virus infection",
author = "Maadhava Ellaurie and Arye Rubinstein",
year = "1990",
language = "English (US)",
volume = "9",
pages = "807--809",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection

AU - Ellaurie, Maadhava

AU - Rubinstein, Arye

PY - 1990

Y1 - 1990

N2 - Serum concentrations of beta-2-microglobulin (B2-M) were correlated with disease outcome in 40 children infected by the human immunodeficiency virus. Serum B2-M serum concentrations below 3.0 mg/100 ml or decreasing concentrations were indicative of a stable disease course but were also noted preterminally in lymphopenic children. Of 20 patients with B2-M concentrations above 3.0 mg/liter, 12 had a progressive disease course and 8 remained stable. In the latter 8 patients the B2-M values decreased with time. Elevated B2-M concentrations were also noted in infants younger than 1 year of age and denoted active human immunodeficiency virus infection. B2-M serum concentrations are a useful prognostic marker in human immunodeficiency virus-infected children.

AB - Serum concentrations of beta-2-microglobulin (B2-M) were correlated with disease outcome in 40 children infected by the human immunodeficiency virus. Serum B2-M serum concentrations below 3.0 mg/100 ml or decreasing concentrations were indicative of a stable disease course but were also noted preterminally in lymphopenic children. Of 20 patients with B2-M concentrations above 3.0 mg/liter, 12 had a progressive disease course and 8 remained stable. In the latter 8 patients the B2-M values decreased with time. Elevated B2-M concentrations were also noted in infants younger than 1 year of age and denoted active human immunodeficiency virus infection. B2-M serum concentrations are a useful prognostic marker in human immunodeficiency virus-infected children.

KW - Acquired immunodeficiency syndrome

KW - Beta-2-microglobulin

KW - Early markers

KW - Human immunodeficiency virus infection

UR - http://www.scopus.com/inward/record.url?scp=0024998087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024998087&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 807

EP - 809

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -